1
|
T WolvertonM LalandeIdentification and
characterization of three members of a novel subclass of
protocadherinsGenomics766672200110.1006/geno.2001.659211549318
|
2
|
SY KimS YasudaH TanakaK YamagataH
KimNon-clustered protocadherinCell Adh
Migr597105201110.4161/cam.5.2.1437421173574
|
3
|
J YingH LiTJ SengFunctional epigenetics
identifies a protocadherin PCDH10 as a candidate tumor suppressor
for nasopharyngeal, esophageal and multiple other carcinomas with
frequent
methylationOncogene2510701080200610.1038/sj.onc.1209154
|
4
|
Z LiJ XieW LiIdentification and
characterization of human PCDH10 gene
promoterGene4754956201110.1016/j.gene.2011.01.00121237250
|
5
|
KC BertrandSC MackPA NorthcottPCDH10 is a
candidate tumour suppressor gene in medulloblastomaChilds Nerv
Syst2712431249201110.1007/s00381-011-1486-x21597995
|
6
|
PA JonesSB BaylinThe fundamental role of
epigenetic events in cancerNat Rev Genet3415428200212042769
|
7
|
PA JonesPW LairdCancer epigenetics comes
of ageNat Genet21163167199910.1038/59479988266
|
8
|
SB BaylinJG HermanDNA hypermethylation in
tumorigenesis: epigenetics joins geneticsTrends
Genet16168174200010.1016/S0168-9525(99)01971-X10729832
|
9
|
N GiulianiP StortiM BolzoniBD PalmaS
BonominiAngiogenesis and multiple myelomaCancer MicroenvironJuly
72011(Epub ahead of print)
|
10
|
KC AndersonRD CarrascoPathogenesis of
myelomaAnnu Rev
Pathol6249274201110.1146/annurev-pathol-011110-130249
|
11
|
K AsosinghH De RaeveE MenuAngiogenic
switch during 5T2MM murine myeloma tumorigenesis: role of CD45
heterogeneityBlood10331313137200410.1182/blood-2003-08-294615070695
|
12
|
JS KimHK YuJH AhnHuman apolipoprotein(a)
kringle V inhibits angiogenesis in vitro and in vivo by interfering
with the activation of focal adhesion kinasesBiochem Biophys Res
Commun313534540200410.1016/j.bbrc.2003.11.14814697222
|
13
|
E CrivellatoB NicoA VaccaV DjonovM PrestaD
RibattiRecombinant human erythropoietin induces intussusceptive
microvascular growth in
vivoLeukemia18331336200410.1038/sj.leu.240324614671634
|
14
|
M EstellerRA RisquesM ToyotaPromoter
hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is
associated with the presence of G:C to A:T transition mutations in
p53 in human colorectal tumorigenesisCancer
Res6146894692200111406538
|
15
|
M CravoP FidalgoAD PereiraDNA methylation
as an intermediate biomarker in colorectal cancer: modulation by
folic acid supplementationEur J Cancer
Prev3473479199410.1097/00008469-199411000-000047858479
|
16
|
PW LairdR JaenischDNA methylation and
cancerHum Mol Genet3Spec No: 1487–14951994
|
17
|
HK KuoJD GriffithKN Kreuzer5-Azacytidine
induced methyltransferase-DNA adducts block DNA replication in
vivoCancer
Res6782488254200710.1158/0008-5472.CAN-07-103817804739
|
18
|
I SonodaI ImotoJ InoueFrequent silencing
of low density lipoprotein receptor-related protein 1B (LRP1B)
expression by genetic and epigenetic mechanisms in esophageal
squamous cell carcinomaCancer
Res6437413747200410.1158/0008-5472.CAN-04-0172
|
19
|
I ImotoY YukiI SonodaIdentification of
ZASC1 encoding a Kruppel-like zinc finger protein as a novel target
for 3q26 amplification in esophageal squamous cell carcinomasCancer
Res6356915696200314522885
|
20
|
PA JonesD TakaiThe role of DNA methylation
in mammalian
epigeneticsScience29310681070200110.1126/science.106385211498573
|
21
|
BA WalkerCP WardellL ChiecchioAberrant
global methylation patterns affect the molecular pathogenesis and
prognosis of multiple
myelomaBlood117553562201110.1182/blood-2010-04-27953920944071
|
22
|
E Martinez-GarciaR PopovicDJ MinThe MMSET
histone methyl transferase switches global histone methylation and
alters gene expression in t(4;14) multiple myeloma
cellsBlood117211220201110.1182/blood-2010-07-29834920974671
|
23
|
AV SinghM BandiN RajeA novel vascular
disrupting agent plinabulin triggers JNK-mediated apoptosis and
inhibits angiogenesis in multiple myeloma
cellsBlood11756925700201110.1182/blood-2010-12-323857
|
24
|
A VaccaD RibattiAngiogenesis and
vasculogenesis in multiple myeloma: role of inflammatory
cellsRecent Results Cancer
Res1838795201110.1007/978-3-540-85772-3_421509681
|
25
|
Y ZhangY DaakaPGE2 promotes angiogenesis
through EP4 and PKA Cγ pathwayBlood11853555364201121926356
|
26
|
M PotenteH GerhardtP CarmelietBasic and
therapeutic aspects of
angiogenesisCell146873887201110.1016/j.cell.2011.08.03921925313
|
27
|
FJ CarmonaM EstellerIDIBELL Cancer
conference on metastasis and angiogenesisCancer
Res7160976101201110.1158/0008-5472.CAN-11-218021933886
|
28
|
KS CohenAngiogenesis and multiple myeloma:
is there a role for angiogenic biomarkers in the context of
autologous stem cell transplant?Leuk
Lymphoma5211731175201110.3109/10428194.2011.59100921699381
|
29
|
Y OkiJ JelinekL ShenHM KantarjianJP
IssaInduction of hypomethylation and molecular response after
decitabine therapy in patients with chronic myelomonocytic
leukemiaBlood11123822384200810.1182/blood-2007-07-10396018055864
|
30
|
K BalassianoS LimaM JenabAberrant DNA
methylation of cancer-associated genes in gastric cancer in the
European Prospective Investigation into Cancer and Nutrition
(EPIC-EURGAST)Cancer
Lett3118595201110.1016/j.canlet.2011.06.03821831520
|
31
|
DJ StewartJP IssaR KurzrockDecitabine
effect on tumor global DNA methylation and other parameters in a
phase I trial in refractory solid tumors and lymphomasClin Cancer
Res1538813888200910.1158/1078-0432.CCR-08-219619470736
|
32
|
E FabianiG LeoneM GiacheliaAnalysis of
genome-wide methylation and gene expression induced by
5-aza-2′-deoxycytidine identifies BCL2L10 as a frequent methylation
target in acute myeloid leukemiaLeuk Lymphoma51227522842010
|